Supporting Every Heart

Making Advanced
Cardiac Care Affordable

CardioLife is developing next-generation cardiac support technologies designed to improve patient outcomes & expand access to advanced heart care worldwide.

The Reality of Cardiac Care

Millions of people require advanced cardiac support, yet access to treatment remains limited worldwide.

56 Million

People living with cardiac conditions worldwide

3.2 Million

People in advanced stages requiring specialised support

27k

People currently receiving advanced cardiac support

Less than 1%

People who receive the advanced cardiac support they require

Why It’s Limited

Despite advances in cardiac care, several barriers continue to limit access to specialized treatment worldwide.

Fragmented Treatments

Current cardiac technologies require multiple separate systems, creating complexity in care delivery.

Access & Affordability

Advanced cardiac devices remain unaffordable in many regions, particularly in low and middle-income countries.

Patient Fit Limitations

Existing devices don't account for the full range of patient anatomies, limiting who can benefit.

Our Products

A Unified Platform

CardioLife brings together advanced cardiac support technologies on a single platform, designed to support patients across different stages of care.

Universal Console Architecture (UCA)

Foundational control and monitoring platform underpinning ECMO and ventricular assist systems

Universal Console Architecture (UCA)

EasyFlow ECMO

Life support for severe heart or lung conditions.

EasyFlow ECMO

External VAD

Used after initial stabilisation for short- to mid-term ventricular support

External VAD

EasyHeart LVAD

Implant for permanent ongoing cardiac support

EasyHeart LVAD
Our Partners

Partnering with Clinical Leaders

We work closely with leading cardiac specialists to ensure our solutions are grounded in real clinical practice.

Clinical Collaboration

Guided by cardiologists and cardiac surgeons across India & Australia.

Expert Advisory Board

Guided by cardiologists and cardiac surgeons across India and Australia.

Hospital Partnerships

Including KIMS Hospital Group (India) and St Vincent’s Hospital, Sydney.

Our Founder

What Led to CardioLife

Behind CardioLife is a journey shaped by personal experience and years in cardiac care.
Hear from our founder, Dr Pete Ayre, on what is needed to change, and the thinking behind making advanced circulatory cardiac support more accessible

Clinical Development

Validated Through Real-World Care

CE Mark and TGA-approved VentrAssist achieved 420+ implants with the longest tracked patient survival of 13 years, demonstrating haemocompatibility and device durability. The team who developed VentrAssist are developing EasyHeart

Comprehensive bench testing and animal studies demonstrating safety and efficacy.

Clinical studies to assess safety, performance, and use in real-world settings.

Designed for clinical workflows in hospital settings, supporting effective and practical use.

We are pursuing TGA approval in Australia and CDSCO registration in India, with CE Mark pathways for future European market access.

Join Us in Advancing Cardiac Care

Better cardiac care is built by clinicians, hospitals, and partners working together to reach more people. If you share this vision, we'd love to connect.